Publication | Closed Access

Polybacterial immunomodulator Respivax restores the inductive function of innate immunity in patients with recurrent respiratory infections

AsthmaMucosal VaccinationHost ResponseInnate Immune SystemImmunologyInductive FunctionRespiratory InfectionInfectious Respiratory DiseaseInnate ImmunityPolybacterial Immunomodulator RespivaxImmunotherapyMedicineRecurrent Respiratory Infections